WALTHAM, Mass., March 05, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating in three upcoming investor conferences.
Read more at globenewswire.comRepligen Corporation to Present at Upcoming March Conferences
Provided By GlobeNewswire – Last update: